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Abstract 9 
The present study introduces powder embossing as a novel method to enhance loading of polymeric microcontainers 10 
with drug. With current loading approaches, it is not possible to handle pure powder drug in a scalable, homogenous 11 
and reproducible manner. In this work, we demonstrate simultaneous loading of 625 microcontainers with powder 12 
formulation. This is achieved in a single step by aligning a shadow mask prepared by micro-milling to an array of 13 
microcontainers in order to limit drug deposition to the container cavities with diameters of 220 µm. A pressure of 8.9 14 
MPa is applied by a bonding press and thereby the desired powder is embossed into the container cavities. Powder in 15 
the form of pure drug, lipid-based microparticles, and pure polymer was successfully loaded with minimal residues in 16 
between the microcontainers and with 100% loaded cavities demonstrating the versatility of the method. The current 17 
work is thus contributing to the loading of powder formulations into microscale drug delivery systems such as 18 
microcontainers in a facile and reproducible manner.  19 
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1 Introduction 21 
In recent years, microfabricated devices have been proposed as advanced drug delivery systems [1][2][3]. 22 
Microfabrication methods allow the definition of devices with well-defined geometry and size containing a precise 23 
amount of drug in each unit and enabling controlled release. In particular, microcontainers  have been presented as 24 
promising new advanced oral drug delivery systems with the potential to significantly enhance the bioavailability of 25 
drugs[4][5][6]. These microcontainers consist of walls and a bottom defining a drug reservoir with a volume in the pL 26 
to nL range. In contrast to the traditional oral drug delivery systems such as tablets, microcontainers provide a larger 27 
surface to volume ratio. This, in some cases combined with the integration of mucoadhesive features, promotes 28 
attachment of the drug delivery systems to the intestinal mucosa and a unidirectional drug release due to a cavity open 29 
only on one side [7]. Due to their small dimensions, one of the major challenges is to load drug into the 30 
microcontainers. A suitable method has to avoid damaging the drug while achieving a homogeneous and reproducible 31 
loading.  32 
In the past, various methods for drug loading into microcontainers have been proposed. Ainslie et al. proposed UV 33 
crosslinking of hydrogel matrices with drug. However the amount of drug that can be loaded with this approach is very 34 
restricted [8][3]. Alternatively, hot punching in a spin-coated drug-polymer film or supercritical impregnation of 35 
microcontainers filled with polymer by inkjet-printing were demonstrated [9][10]. In all these methods, solubility of the 36 
drug in the polymer matrix is required. Furthermore, the polymer matrix itself will occupy a considerable part of the 37 
container volume thereby reducing the amount of drug that can be loaded.  38 
Typically, drugs are available as powder acquired from commercial suppliers or prepared by spray drying and it is 39 
relevant to develop a technique where pure powder drug can be loaded into the microcontainers.  40 
In the existing powder filling method for polymeric microcontainers [11], the powder is manually deposited on the 41 
microcontainers and compacted with a spatula. The residual amount of drug between the containers is blown away with 42 
pressurized air. This method is not applicable for sticky powder such as spray-dried lipid-based microparticles. 43 
Moreover, this method provides irreproducible loading and results in considerable waste of drug due to the use of 44 
pressurized air both removing powder in-between but often also from the upper part of the container reservoir.  45 
Here, we present an improved method for loading microcontainers with powder formulation. This is achieved by 46 
clamping a shadow mask between arrays of microcontainers followed by embossing of the desired powder formulation 47 
into the cavities of the microcontainers. The overall concept is illustrated in figure 1. 48 
2 
 
The shadow mask allows a more precise loading of powder formulations as manual distribution of powder and the use 49 
of the pressurized air can be avoided. For the fabrication of shadow masks, a large number of materials and methods 50 
have been suggested for other applications. Silicon (Si) shadow masks have been used for metal evaporation or local 51 
plasma polymerization[12][13]. A ferromagnetic Ni shadow mask was presented to allow the use of magnetic forces to 52 
provide clamping between substrate and stencil[14]. However, in both cases preparation of the shadow masks is both 53 
time consuming and requires various cleanroom processes. In this work, a micro-milled aluminum shadow mask is 54 
suggested with the purpose of embossing powder into the container cavities without leaving residues around the 55 
microcontainers. In order to explore the versatility of this method, spray-dried lipid-based micro-particles, drug in pure 56 
form and polymer are loaded into the containers.  57 
 58 
Figure 1 Illustration of the method for loading micro containers with powder formulation. (a) SU-8 microcontainers (blue) fabricated 59 
on Si carrier substrate (grey); (b) the shadow mask (brown) is clamped to the microcontainers. Powder formulation (red) is placed in 60 
a holder in order to have equal amount of powder in each loading step and pressure is applied (c) After the pressure is released (d) the 61 
shadow mask is removed and the containers are uniformly loaded with powder. 62 
 2 Materials and methods 63 
 64 
2.1 SU-8 microcontainers 65 
Silicon wafers (4-in. b100N n-type) were supplied by Okmetic (Vantaa, Finland). SU-8 2075, SU-8 2035 and SU-8 66 
developer were purchased from Microresist Technology GmbH (Berlin, Germany). Cylindrical SU-8 microcontainers 67 
were fabricated on Si substrates with a similar method as described previously [11]. The microcontainers had an outer 68 
diameter of 300 µm and a height of 300 µm. The microcontainer reservoir had a diameter of 220 µm and a depth of 270 69 
µm. Following fabrication, the wafer was cut into 12.8x12.8 mm2 square chips (DISCO DAD 321, Automatic Dicing 70 
Saw). Each of these microcontainer chips contained 625 microcontainers arranged in an array of 25x25 with a center-to-71 
center distance of 450 µm.  72 
 73 
2.2 Micro-milling of shadow mask and alignment tool  74 
The shadow mask was designed using solidworks and micro-milling procedures were generated using Cimatron. 300 75 
µm and 1 mm endmill tools were used for fabrication of the mask through micro-milling in 300 µm thick aluminum 76 
sheets. The side length of the shadow mask was 15x15 mm2.  The holes of the shadow mask had a diameter of 380 µm 77 
and a center-to-center distance of 450 µm. A separate alignment tool for the shadow mask was fabricated for an easy 78 
alignment and clamping to the microcontainers as illustrated in figure 2.  79 
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 80 
Figure 2 Illustration of the clamping of the shadow mask (a) onto the microcontainer chip with an array of 625 microcontainers (b). 81 
A separate bottom part (c) is designed to facilitate alignment of the shadow mask to the container chip.  82 
 83 
2.3 Powder embossing for drug loading  84 
The fabricated shadow mask was clamped to the array of microcontainers. For uniform transfer of the powder to the 85 
containers, the desired powder formulation was placed in a micro-milled recess with lateral dimensions of 15 mm2 and a 86 
depth of 1 mm. By applying a pressure of 8.9 MPa (force 2 kN) with a bonding press (P/O/Weber), the powder was 87 
embossed inside the container cavities after which the pressure and shadow mask were gently removed. The remaining 88 
powder was reused for loading of following samples. Microcontainer chips were loaded with three different powder 89 
formulations: Furosemide (≥98% purity) was purchased from Fagron Nordic (Copenhagen, Denmark) as a model for 90 
pure drug powder loading; Polyvinylpyrrolidone (PVP) with an average mol wt 10,000 Da (K10) was purchased from 91 
Sigma-Aldrich (St. Louis) to evaluate loading of pure polymer powder; lipid-based microparticles in the form of empty 92 
cubosomes were prepared by spray drying with a similar method as described in an earlier study, here without addition 93 
of ovalbumin [15]. The investigations were carried out using ZEISS Supra 40 VP SEM. The samples were sputtered 94 
with Au before imaging to avoid charging of the non-conducting materials.  95 
 96 
2.4 X-Ray microtomography 97 
Sample chips as described in section 2.1 were analysed using a commercial X-ray microtomography versa system 98 
(Zeiss Xradia 410). The system has an X-ray source operated in reflection geometry, a working high voltage between 99 
40 kV and 150 kV and a power up to 10W.  100 
Samples were mounted on a flat seam in order to enable alignment to ensure that they were within the field of view in 101 
the horizontal plane of the detector. A source voltage of 60 kV and power of 10 W were used for all measurements in 102 
combination with different objectives. Each sample was imaged first with a low resolution using the Large Field Of 103 
View objective (19.68 µm pixels and a collection time of 2 hours, using 1601 projection Images to cover 360 degrees 104 
rotation) in order to observe the entire chip of 625 containers. Then, an area of interest was selected for further 105 
investigation with a higher resolution (3.02 µm pixels and a collection time of 5.5 hours with 3201 projection images 106 
covering 360 degree rotation) to properly investigate the loading of 25 microcontainers using the ‘4X’ objective. Single 107 
containers were selected for thorough inspection with an even higher resolution (1.21 µm pixels with a collection time 108 
of 19 hours while rotating the sample 360 degrees in 3201 projection images). Tomographic data were reconstructed 109 
using the commercial software available for the system. The reconstruction software is based on the FDK method which 110 
is a filtered back projection algorithm[16]. 111 
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2.5 In vitro drug release study of furosemide from microcontainers 112 
The in vitro release of furosemide from the microcontainers was tested using a µ-Diss profiler (pION INC, Woburn, 113 
MA, USA) in a similar set-up as described earlier (Nielsen et al., 2015, 2014). Experiments were carried out at 37⁰C 114 
employing a stirring rate of 100 rpm. The path length of the in situ UV probes was 1 mm, and each channel of the 115 
profiler was calibrated with its own standard curve prior to the experiments. The loaded microcontainer chips were 116 
attached to cylindrical magnetic stirring bars using carbon pads, placed in the bottom of sample vials, and covered with 117 
10 mL of 100 mM phosphate buffer pH 6.5 for 20 h. The experiment was performed in 5 replicates (N=5).  118 
3 Results and discussion  119 
 120 
3.1 Alignment of shadow mask and powder embossing into microcontainers  121 
Figure 3a-c shows that it was possible to achieve a perfect alignment and clamping of the containers to the shadow 122 
mask by placing a silicon chip with microcontainers on the alignment tool and then positioning the shadow mask on top 123 
of the containers. A successful loading is characterized by drug inside all container cavities. The powder filling required 124 
few seconds to be performed and resulted all of the 625 microcontainers in the array loaded in one single step 125 
corresponding to 100 % yield. This is shown for the three powder formulations with representative images in figure 3d-126 
f. The powder granules were pressed into the containers and this confinement prevented them from falling out of the 127 
reservoir. Minimal residues in between the containers were observed.  Despite the simplicity of the method, the SEM 128 
images show a uniform loading in each container.  The average amount of micro-particles in the form of cubosomes 129 
was 1.7 ± 0.2 mg chips (n=5 chips), furosemide had an average weight of 1.5 ± 0.4 mg (n=5 chips), and PVP 1.3 ± 0.2 130 
mg (n=5 chips). This corresponds to 2.7 µg/container, 2.5 µg/container and 2.1 µg/container, respectively.  131 
 132 
3.2 Loading of particles with different morphology 133 
X ray microtomography measurements have previously successfully been used to visualize the effect of loading 134 
procedures into microcontainers  [10].  To visualize the effect of the process on the powder and to verify if the container 135 
reservoirs were completely filled, X-ray microtomography measurements were performed on the microcontainers 136 
loaded with the powder embossing method. As seen in the cross-sections reconstructed from X-ray microtomography 137 
measurements in figure 4a-c, all three powder formulations were successfully loaded inside the containers using the 138 
powder embossing method. Due to different particle morphology and size of the three powder types their distribution in 139 
the containers was different. The small lipid-based microparticles were compacted inside the containers without any 140 
inclusion of air. Furosemide was also densely packed inside the containers but some air was observed. Containers 141 
loaded with PVP displayed the presence of more spacing between the powder granules compared to the two previous 142 
materials. However, the loading with PVP was much more uniform compared to earlier work where containers were 143 
loaded without embossing [10]. These images demonstrate the variety of powders that can be loaded with this method.  144 
  145 
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Figure 3 SEM micrograph showing arrays and zoom images in the inserts of: a) SU-8 containers of 300 µm outer diameter and 
300 µm height; b) the fabricated aluminum shadow mask with 380 µm circular holes; c) the microcontainers aligned with the 
fabricated shadow mask; microcontainers loaded with d) lipid-based microparticles, e) furosemide and f) PVP (K10) inside the 
container cavities using the powder embossing method  
146 
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 149 
Figure 4 Cross-sections acquired by XµCT through the microcontainers filled with a) PVP (K10), b) lipid-based microparticles in 150 
the form of cubosomes, c) furosemide, 151 
3.3 Release of furosemide from microcontainers 152 
The release of furosemide from the containers was investigated in a medium with similar pH value as intestinal fluid 153 
(pH 6.5). Furosemide showed a two phased release (figure 5); the first phase was very rapid for 30 minutes where 40 % 154 
of the drug was released. This was expected as any possible loose powder on the top of the containers would be 155 
detected in the media almost simultaneously. Then, a slower diffusion rate occurred as the pressed powder from inside 156 
the containers was released. This rate continued until almost 100 % of the drug (1.5±0.2 mg/chip) was released from the 157 
containers. The fact that the signal was absorbed at UV wavelengths ranging from 310-350 nm indicates that the 158 
loading process did not affect furosemide at a chemical level as it would have absorbed at another wavelength 159 
otherwise. Also, the release curve is similar to other release studies of crystalline furosemide (data not shown). SEM 160 
micrographs of the containers after the release experiments confirm that the containers were emptied (Figure 6a). A few 161 
residues of powder were observed at the bottom of the containers reservoirs confirming the fact that the release profile 162 
did not reach exactly 100% of the weighed amount of drug. Similar release experiments were conducted for the 163 
containers loaded with lipid-based microparticles and PVP (Figure 6b-c). The micrographs after the microparticle 164 
release studies showed that significantly more powder residue was left after the release experiments which might be due 165 
to the dense filling and the sticky nature of the cubosomes. The empty PVP containers (Figure 6c) demonstrate that 166 
close to 100 % of the powder was released from the containers. Also, investigation of cubosomes in cryo-TEM before 167 
and after loading demonstrated that the microparticles were not affected by the pressure (data not shown). 168 
 169 
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Figure 5 In vitro release profiles obtained from SU-8 microcontainers filled with furosemide in phosphate buffer (intestinal medium) 173 
at pH 6.5. Data is presented as average of 5 release studies +SD.  174 
 175 
       176 
Figure 6 SEM micrographs of microcontainers after release in PBS pH 6.5 for 20 hours of a), furosemide b) lipid-based 177 
microparticles in the form of cubosomes, and c) polyvinylpyrollidone.  178 
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4 Conclusion  180 
Here, we introduced powder embossing as a new method for loading of powder into microcontainers for oral drug 181 
delivery. For this purpose, the successful fabrication of an aluminum shadow mask with micro-milling process had to be 182 
demonstrated. Alignment and clamping of the shadow mask around the containers prevented deposition of drug 183 
between the microcontainers and restricted drug loading to the microcontainer cavities. Application of pressure allowed 184 
loading the container reservoirs with various powder formulations such as furosemide, polyvinylpyrrolidone and lipid-185 
based microparticles in the form of cubosomes demonstrating the versatility of the method. An excellent loading 186 
efficiency, homogeneity, and reproducibility was confirmed by weighing, SEM imaging and X-ray microtomography 187 
measurements. Furthermore, waste of drug powder was minimized. The yield for the powder embossing was 100% for 188 
simultaneous loading of 625 microcontainers. The throughput of the method can potentially be increased by fabrication 189 
of larger arrays of microcontainers and corresponding shadow masks.  190 
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